Variant report
Variant | esv33332 |
---|---|
Chromosome Location | chr15:30282956-30285872 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs141492476 | chr15:30282964-30282965 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs557433024 | chr15:30282967-30282968 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs577289684 | chr15:30283040-30283041 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs533558119 | chr15:30283048-30283049 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs532225912 | chr15:30283171-30283172 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs553759726 | chr15:30283197-30283198 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs573553979 | chr15:30283198-30283199 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs16954892 | chr15:30283217-30283218 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs568864056 | chr15:30283265-30283266 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs78615869 | chr15:30283289-30283290 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs150847948 | chr15:30283299-30283300 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs191849624 | chr15:30283322-30283323 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs182500087 | chr15:30283408-30283409 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs564588744 | chr15:30283462-30283463 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs533497622 | chr15:30283467-30283468 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs540343608 | chr15:30283478-30283479 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs569525834 | chr15:30283479-30283480 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs139283716 | chr15:30283556-30283557 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs529260842 | chr15:30283559-30283560 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs142817641 | chr15:30283577-30283578 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs147396155 | chr15:30283578-30283579 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs115605516 | chr15:30283648-30283649 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs551524765 | chr15:30283785-30283786 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs374840577 | chr15:30283800-30283801 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs571486204 | chr15:30283830-30283831 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs145285231 | chr15:30283834-30283835 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs553578087 | chr15:30283876-30283877 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs567264207 | chr15:30283927-30283928 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs56290869 | chr15:30283950-30283951 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
30 | rs556445586 | chr15:30284011-30284012 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs554556613 | chr15:30284013-30284014 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs373367031 | chr15:30284025-30284026 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs187547097 | chr15:30284030-30284031 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs143907499 | chr15:30284105-30284106 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs79330861 | chr15:30284112-30284113 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs57284284 | chr15:30284165-30284166 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
37 | rs540759547 | chr15:30284188-30284189 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs560342107 | chr15:30284201-30284202 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs111921208 | chr15:30284248-30284249 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs542626382 | chr15:30284251-30284252 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs553527985 | chr15:30284274-30284275 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs554077917 | chr15:30284275-30284276 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs531916118 | chr15:30284290-30284291 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs540781264 | chr15:30284295-30284296 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs117240077 | chr15:30284321-30284322 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs192124746 | chr15:30284358-30284359 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs185743155 | chr15:30284359-30284360 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs574642754 | chr15:30284379-30284380 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs541744212 | chr15:30284381-30284382 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs536263241 | chr15:30284385-30284386 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Ovarian cancer | 21720365 | CNVD |
HDAC8 | 0 | CNVD |
NIPBL | 0 | CNVD |
RAD21 | 0 | CNVD |
SMC1A | 0 | CNVD |
SMC3 | 0 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Schizophrenia | 19415332 | CNVD |
Breast cancer | 22522925 | CNVD |
Autism | 22495311 | CNVD |
Wilms tumour | 21544195 | CNVD |
Prader-willi syndrome | 21504564 | CNVD |
The inv dup or idic syndrome | 19019226 | CNVD |
Prader-willi syndrome | 21233802 | CNVD |
Angelman syndrome | 16617304 | CNVD |
Angelman syndrome | 20970697 | CNVD |
Autism | 22958593 | CNVD |
Prader-willi syndrome | 16617304 | CNVD |
Prader-willi syndrome | 18923514 | CNVD |
Prader-willi syndrome | 20970697 | CNVD |
Angelman syndrome | 16183798 | CNVD |
Angelman syndrome | 18923514 | CNVD |
Prader-willi syndrome | 22241247 | CNVD |
Epilepsy | 20970697 | CNVD |
Autism | 20970697 | CNVD |
Autism | 19935738 | CNVD |
Autism | 22930557 | CNVD |
Autism | 19966786 | CNVD |
Autism | 18923514 | CNVD |
Autism | 18925931 | CNVD |
Autism | 18835857 | CNVD |
Prader-willi syndrome | 18835857 | CNVD |
Prader-willi syndrome | 22152151 | CNVD |
Autism | 22241247 | CNVD |
15q-syndrome | 21725066 | CNVD |
Prader-willi syndrome | 21503198 | CNVD |
Autism | 21956041 | CNVD |
Prader-willi syndrome | 16760730 | CNVD |
Prader-willi syndrome | 22470819 | CNVD |
prenatal diagnosis | 20453657 | CNVD |
Prader-willi syndrome | 17867985 | CNVD |
Angelman syndrome | 21072004 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
cataract | 16735990 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Medulloblastoma | 21979893 | CNVD |
spastic paraplegia with thinning of corpus callosum | 19105190 | CNVD |
Schizophrenia | 21324950 | CNVD |
Astrocytoma | 17387387 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Disease | 21824424 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Prader-willi syndrome | 18781185 | CNVD |
Melanoma | 18172304 | CNVD |
Autism | 17322880 | CNVD |
Prader-willi syndrome | 19329560 | CNVD |
Autism | 17999366 | CNVD |
Autism | 17901113 | CNVD |
Neurodevelopmental disorder | 17015230 | CNVD |
Autism | 18414403 | CNVD |
Neurocytoma | 17123091 | CNVD |
Mental retardation | 18923513 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Gastric cancer | 17167181 | CNVD |
Neuroblastoma | 19435921 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Intellectual disability | 22102821 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Breast cancer | 21509527 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Breast cancer | 17133270 | CNVD |
Prostate cancer | 16573809 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Multiple myeloma | 20724749 | CNVD |
Schizophrenia | 19197363 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 21858162 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Breast cancer | 21785460 | CNVD |
Prostate cancer | 18632612 | CNVD |
Angelman syndrome | 18787571 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Abnormal corpus callosum | 21572526 | CNVD |
idiopathic generalized epilepsy | 19843651 | CNVD |
Autism | 20531469 | CNVD |
Neuropsychiatric disorder | 20506139 | CNVD |
Austim spectrum disorder | 21302340 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Mental retardation | 17124404 | CNVD |
Autism | 19204725 | CNVD |
Schizophrenia | 19204725 | CNVD |
Schizophrenia | 19149910 | CNVD |
Schizophrenia | 20967226 | CNVD |
Non-syndromic sensorineural hearing loss | 18496225 | CNVD |
Autism | 19843651 | CNVD |
Schizophrenia | 19843651 | CNVD |
Schizophrenia | 23813976 | CNVD |
Cognitive impairment | 21505072 | CNVD |
Autism | 22543975 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Autism | 22495309 | CNVD |
Schizophrenia | 20388499 | CNVD |
Epilepsy | 22499536 | CNVD |
Schizophrenia | 22499536 | CNVD |
Schizophrenia | 18923514 | CNVD |
Bipolar disorder | 19114987 | CNVD |
Schizophrenia | 20587603 | CNVD |
Schizophrenia | 22958593 | CNVD |
Schizophrenia | 21285140 | CNVD |
Schizophrenia | 20553308 | CNVD |
Schizophrenia | 21956041 | CNVD |
Schizophrenia | 20970697 | CNVD |
Mental retardation | 19951919 | CNVD |
Mental retardation | 21956041 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Mental retardation | 21062444 | CNVD |
Autism | 21269290 | CNVD |
Intellectual disability | 21269290 | CNVD |
Schizophrenia | 21269290 | CNVD |
Colorectal cancer | 21128281 | CNVD |
Epilepsy | 19289393 | CNVD |
Epilepsy | 20643615 | CNVD |
Mental retardation | 19289393 | CNVD |
Mental retardation | 20152051 | CNVD |
Schizophrenia | 19289393 | CNVD |
dysmorphic features | 19289393 | CNVD |
idiopathic epilepsies | 19341504 | CNVD |
idiopathic generalized epilepsy | 19592580 | CNVD |
idiopathic generalized epilepsy | 19136953 | CNVD |
Autism | 22094647 | CNVD |
Developmental delay | 19898479 | CNVD |
Mental retardation | 18278044 | CNVD |
Mental retardation | 19898479 | CNVD |
Prader-willi syndrome | 18854863 | CNVD |
Schizophrenia | 19855392 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Non-syndromic sensorineural hearing loss | 21293372 | CNVD |
Cancer | 20164919 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr15:30277800-30283400 | Weak transcription | Brain Angular Gyrus | brain |
2 | chr15:30280800-30286000 | Weak transcription | Fetal Adrenal Gland | Adrenal Gland |
3 | chr15:30281200-30283600 | Enhancers | Brain Hippocampus Middle | brain |
4 | chr15:30281400-30283600 | Weak transcription | Brain Inferior Temporal Lobe | brain |
5 | chr15:30281400-30293600 | Weak transcription | Brain Cingulate Gyrus | brain |
6 | chr15:30282000-30285800 | Weak transcription | HUES48 Cell Line | embryonic stem cell |
7 | chr15:30282000-30285800 | Weak transcription | iPS-20b Cell Line | embryonic stem cell |
8 | chr15:30282400-30286000 | Weak transcription | Ganglion Eminence derived primary cultured neurospheres | brain |
9 | chr15:30282600-30285600 | Weak transcription | Cortex derived primary cultured neurospheres | brain |
10 | chr15:30282600-30292600 | Weak transcription | Brain Substantia Nigra | brain |
11 | chr15:30283000-30283600 | Enhancers | Hela-S3 | cervix |
12 | chr15:30283400-30283600 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
13 | chr15:30283400-30283600 | Enhancers | Brain Angular Gyrus | brain |
14 | chr15:30283600-30283800 | Enhancers | Brain Inferior Temporal Lobe | brain |
15 | chr15:30283600-30285600 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
16 | chr15:30283600-30293000 | Weak transcription | Brain Hippocampus Middle | brain |
17 | chr15:30285600-30286600 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
18 | chr15:30285600-30286600 | Enhancers | Cortex derived primary cultured neurospheres | brain |
19 | chr15:30285800-30286200 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
20 | chr15:30285800-30286400 | Enhancers | HUES64 Cell Line | embryonic stem cell |
21 | chr15:30285800-30286600 | Enhancers | HUES48 Cell Line | embryonic stem cell |